Abbott Laboratories has agreed to pay nearly $385 million to settle allegations involving the safety and manufacturing of some of its powdered infant formula, the Justice Department announced Monday.

Abbott Laboratories (NYSE:ABT) has agreed to pay more than $384 million to resolve U.S. Justice Department allegations that it knowingly produced infant formula in potentially contaminated environments at its Michigan and Arizona facilities, including allegations of inadequate testing and failure to disclose positive contamination tests to regulators. The settlement resolves civil claims without an admission […]

STURGIS, MI (WKZO AM/FM) - The U.S. Attorney's Office for Western Michigan says Abbott Laboratories has agreed...

Abbott Laboratories stock rose about 1.2 percent on September 14, 2026 after agreeing to a roughly U

Abbott Laboratories (NYSE:ABT) reached a US$385 million settlement tied to the 2022 infant formula recall and Sturgis plant shutdown. The agreement resolves civil claims from families, states, and other plaintiffs alleging product safety failures and gaps in compliance with federal standards. The settlement follows U.S. Department of Justice and multi state investigations into Abbott

Abbott will pay $384,999,040 to settle civil allegations about infant formula made in Michigan and Arizona. The company denies wrongdoing.

Abbott Laboratories (NYSE:ABT) agreed to a US$385 million settlement tied to its 2022 infant formula recall at the Sturgis, Michigan plant. The agreement resolves federal and state investigations into the recall and related nationwide infant formula supply shortages. Regulators closed government criminal probes as part of the settlement, which includes no admission of liability by Abbott. The US$385 million recall settlement that closes criminal probes only captures one dimension of Abbott's...

Oregon Attorney General Dan Rayfield says Abbott Laboratories will pay the state nearly $1 million as part of a settlement over powdered baby formula.